Search results for "Prostate cancer"
Leflunomide gets boxed warning, ARBs under review
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2010/09/fda.htm
1 Sep 2010
A1c predicts cardiovascular disease, death in nondiabetics
A1c predicts cardiovascular disease, death in nondiabeticsGuidelines suggest more informed consent for prostate cancer screening
https://immattersacp.org/weekly/archives/2010/03/09/1.htm
9 Mar 2010
Heparin labeling changed, non-egg flu vaccine approved
This regulatory update covers changed labeling for heparin and approval of a flu vaccine produced using cultured animal cells.
https://immattersacp.org/archives/2013/02/fda.htm
1 Feb 2013
Evidence lacking for routine prostate screening, but single test at 60 may help
Exacerbation-susceptible subtype may exist in COPD
https://immattersacp.org/weekly/archives/2010/09/21/4.htm
21 Sep 2010
Radical prostatectomy may offer advantages over watchful waiting
Men with prostate cancer may survive longer with radical prostatectomy than watchful waiting, especially if they are younger than 65 years of age at diagnosis, a study suggested.
https://immattersacp.org/weekly/archives/2014/03/11/4.htm
11 Mar 2014
Letters to the Editor
PSA tests, fibromyalgia and reconsidering clinical impressions are discussed and debated by ACP members.
https://immattersacp.org/archives/2009/05/letters.htm
1 May 2009
Metastatic disease reduced in PSA screening era, study indicates
Prostate-specific antigen (PSA) screening reduced the number of men presenting with metastatic prostate cancer, a new study found.
https://immattersacp.org/weekly/archives/2012/08/07/2.htm
7 Aug 2012
Warnings on prostate drugs, HIV combination therapy
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/01/fda.htm
1 Jan 2011
Diabetes and cancer links evaluated
Diabetes and cancer links evaluatedMedicare cuts raised chemotherapy treatments, changed drug choices
https://immattersacp.org/weekly/archives/2010/06/22/1.htm
22 Jun 2010
Simulation model suggests active surveillance offers greatest quality-adjusted life expectancy
Recommended therapies after ischemic stroke less likely to be received by the elderly
https://immattersacp.org/weekly/archives/2010/12/07/5.htm
7 Dec 2010